The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension
Information source: China-Japan Friendship Hospital
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Diabetes Mellitus; Essential Hypertension
Intervention: Fosinopril (Drug); Metformin (Drug)
Phase: N/A
Status: Completed
Sponsored by: China-Japan Friendship Hospital
Summary
The objective of this study is to investigate the effect of metformin on the correlation
between hyperinsulinemia and hypertension.
Clinical Details
Official title: The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Blood pressure measurement
Eligibility
Minimum age: 20 Years.
Maximum age: 65 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- 20 to 65 years of age, regardless of sex
- duration of hypertension was <5 years
- overweight or obesity, mild to moderate hypertension, receive no euglycemic agent or
antiobesity drug
Locations and Contacts
Additional Information
Starting date: May 2006
Last updated: May 11, 2011
|